Show Notes
Argilli E et al., The American Journal of Human Genetics - This research letter describes nine unrelated individuals with rare heterozygous missense variants in ABI2, a gene for a cytoskeletal adaptor protein that works in Rac-WAVE signaling and actin remodeling. Seven of them carry the same de novo change, p.Tyr491Cys, in the SH3 domain, and their brain MRIs show a consistent pattern led by a thin corpus callosum, the bundle of fibers that links the two brain hemispheres. Key terms: ABI2, corpus callosum hypoplasia, de novo variant, neurodevelopmental disorder, Rac-WAVE signaling.
Study Highlights:
Individuals were found through exome or genome sequencing and international data sharing via GeneMatcher, with clinical data from medical records and clinician questionnaires and centrally reviewed brain MRIs. Seven individuals carried the recurrent p.Tyr491Cys variant and two carried distinct de novo variants, p.Val204Met and p.Val463Ala; all variants were absent from gnomAD v4.1. All nine had moderate-to-severe developmental delay and/or intellectual disability, epilepsy occurred in six, and macrocephaly ranging from +2.5 to +4.2 SD was seen in seven of eight individuals. Every individual with p.Tyr491Cys showed marked corpus callosum hypoplasia and periventricular T2-FLAIR hyperintensities, while the two individuals with nonrecurrent variants lacked corpus callosum abnormalities.
Conclusion:
The authors establish ABI2 as a neurodevelopmental disorder-associated gene and identify the recurrent p.Tyr491Cys variant as defining a distinctive syndrome with corpus callosum hypoplasia and white matter abnormalities, consistent with other Rac-WAVE pathway disorders and with Abi2-deficient mice. The cohort is small, nine individuals, and the mechanism is inferred from structural modeling and prediction tools; the authors state that future functional studies will be needed to explain how the variants cause disease.
Article title:
Recurrent de novo ABI2 p.Tyr491Cys variants define a neurodevelopmental syndrome with corpus callosum hypoplasia and white matter abnormalities
First author:
Argilli E
Journal:
The American Journal of Human Genetics
DOI:
10.1016/j.ajhg.2026.10.003
Reference:
Argilli E., Yang C., Le C., Retallack H., Elashoff A.M., Parks K., et al. Recurrent de novo ABI2 p.Tyr491Cys variants define a neurodevelopmental syndrome with corpus callosum hypoplasia and white matter abnormalities. The American Journal of Human Genetics. (2026). https://doi.org/10.1016/j.ajhg.2026.10.003
License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/
Support:
Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:
❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01
☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00
▶️ Watch with chapters on YouTube: https://www.youtube.com/@basebybase
More at basebybase.com
On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.
Episode link: https://basebybase.com/episodes/abi2-tyr491cys-corpus-callosum-neurodevelopmental-syndrome
QC:
This episode's script was checked sentence by sentence against the full text of the original article, by an automated process with human review, before it was recorded.
QC Summary:
- sentences checked: 81
- supported by the article: 80
- flagged and reviewed by a human: 1
- metadata checks passed: 4 of 4
QC result: Pass.
Chapters
- (00:00:03) - A consistent mark on the brain
- (00:01:08) - Intro and fact-check note
- (00:01:29) - Study background and ABI2's biology
- (00:03:22) - Building the cohort
- (00:04:35) - Locating the recurrent variant
- (00:05:13) - Clinical features of affected individuals
- (00:05:49) - Brain MRI findings and the contrast cases
- (00:07:41) - What it all means and pathway links
- (00:08:25) - Limitations of the study
- (00:09:01) - Conclusions and outro